European Pharmaceutical News - Latest
Product name: Nuwiq®, powder and solvent for solution for injection
Active substance: human coagulation factor VIII (rDNA), simoctocog alfa
Manufacturer: Octapharma GmbH
What Nuwiq® is and what it is used for
Nuwiq® contains human recombinant coagulation factor VIII (simoctocog alfa) as the active ingredient. Factor VIII is necessary for blood to clot and bleeding to be stopped. In patients with hemophilia A (congenital factor VIII deficiency), factor VIII is absent or dysfunctional. Nuwiq® replaces the missing factor VIII and is used for the therapy and prevention (prophylaxis) of bleeding in patients with hemophilia.
Nuwiq® can be used in all age groups.
pack sizes
Nuwiq ® 250 IU / Nuwiq ® 500 IU / Nuwiq ® 1000 IU / Nuwiq ® 2000 IU / Nuwiq ® 2500 IU / Nuwiq ® 3000 IU / Nuwiq ® 4000 IU
Powder and solvent for solution for injection to be dissolved in 2.5ml of solvent in pre-filled syringe
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling